Covered recipient · General Payments record
SONIA KAMAL
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2021–2024
$751.85
- Reported across 29 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $288.77 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $123.55 | 8 |
| Lilly USA, LLC | $84.84 | 5 |
| Acerta Pharma LLC | $33.59 | 2 |
| Exact Sciences Corporation | $31.69 | 1 |
| E.R. Squibb & Sons, L.L.C. | $15.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $15.49 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105819489 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.10 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105535532 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.10 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101683065 | CMS |
| Exact Sciences Corporation | $31.69 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114725905 | CMS |
| Lilly USA, LLC | $15.23 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135428350 | CMS |
| Lilly USA, LLC | $18.83 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135428348 | CMS |
| Lilly USA, LLC | $16.77 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135381291 | CMS |
| Lilly USA, LLC | $16.98 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135381293 | CMS |
| Lilly USA, LLC | $17.03 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135429657 | CMS |
| Novo Nordisk Inc | $13.63 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096586966 | CMS |
| Novo Nordisk Inc | $15.47 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097540691 | CMS |
| Novo Nordisk Inc | $15.21 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097429786 | CMS |
| Novo Nordisk Inc | $15.97 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096918352 | CMS |
| Novo Nordisk Inc | $13.85 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096733104 | CMS |
| Novo Nordisk Inc | $16.87 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096728466 | CMS |
| Novo Nordisk Inc | $14.71 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096894973 | CMS |
| Novo Nordisk Inc | $17.84 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096674541 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.